Literature DB >> 16929406

Morbidity related to maternal group B streptococcal infections.

Anouk E Muller1, Paul M Oostvogel, Eric A P Steegers, P Joep Dörr.   

Abstract

Group B streptococcus is known to be a leading cause of neonatal infection, but less appreciated is the fact that it causes maternal infection also. Maternal group B streptococcal infections during pregnancy and delivery threaten not only the mother, but the child as well. Postpartum infection, such as mastitis, bacteremia, sepsis, meningitis, endometritis, and wound infections are hazards to the mother. We describe the various maternal group B streptococcal infections, their characteristics, associated neonatal morbidity, and prevention and treatment strategies during pregnancy, delivery, and in the postpartum period.

Entities:  

Mesh:

Year:  2006        PMID: 16929406     DOI: 10.1080/00016340600780508

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  21 in total

1.  Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection.

Authors:  Chee K Tan; Alison J Carey; Xiangqin Cui; Richard I Webb; Deepak Ipe; Michael Crowley; Allan W Cripps; William H Benjamin; Kimberly B Ulett; Mark A Schembri; Glen C Ulett
Journal:  Infect Immun       Date:  2012-06-25       Impact factor: 3.441

2.  Sacroilitis: an unusual cause for a common presentation.

Authors:  Maliha Shaikh; Hasan Tahir
Journal:  BMJ Case Rep       Date:  2014-09-22

3.  Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection.

Authors:  Kimberly A Kline; Drew J Schwartz; Warren G Lewis; Scott J Hultgren; Amanda L Lewis
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

4.  A Murine Model of Group B Streptococcus Vaginal Colonization.

Authors:  Kathryn A Patras; Kelly S Doran
Journal:  J Vis Exp       Date:  2016-11-16       Impact factor: 1.355

5.  In vitro characterization of PlySK1249, a novel phage lysin, and assessment of its antibacterial activity in a mouse model of Streptococcus agalactiae bacteremia.

Authors:  Frank Oechslin; Jean Daraspe; Marlyse Giddey; Philippe Moreillon; Grégory Resch
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

6.  Diversity of group B streptococcus serotypes causing urinary tract infection in adults.

Authors:  Kimberly B Ulett; William H Benjamin; Fenglin Zhuo; Meng Xiao; Fanrong Kong; Gwendolyn L Gilbert; Mark A Schembri; Glen C Ulett
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

7.  Stable Expression of Modified Green Fluorescent Protein in Group B Streptococci To Enable Visualization in Experimental Systems.

Authors:  Matthew J Sullivan; Glen C Ulett
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

Review 8.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

9.  Group B streptococcus cystitis presenting in a diabetic patient with a massive abdominopelvic abscess: a case report.

Authors:  Kimberly B Ulett; Jennifer H Shuemaker; William H Benjamin; Chee K Tan; Glen C Ulett
Journal:  J Med Case Rep       Date:  2012-08-10

10.  Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients.

Authors:  Chee K Tan; Kimberly B Ulett; Michael Steele; William H Benjamin; Glen C Ulett
Journal:  BMC Infect Dis       Date:  2012-10-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.